Synovial Proteomics in the Clinical Differentiation between Autoimmune and Degenerative Arthritis
DOI:
https://doi.org/10.70577/f2baw318Keywords:
synovial proteomics, rheumatoid arthritis, osteoarthritis, biomarkers, differential diagnosis, personalized medicineAbstract
The clinical differentiation between autoimmune and degenerative arthritis remains a significant challenge due to overlapping clinical manifestations and the limitations of traditional diagnostic methods. In this context, the objective was to analyze the contribution of synovial proteomics as a tool for distinguishing between both conditions through the identification of biomarkers within the articular microenvironment. A descriptive-analytical documentary approach was adopted, based on the review of recent scientific literature and information from national and international organizations, incorporating advanced statistical methods such as multiple linear regression, Spearman correlation, Cronbach’s alpha, and the Shapiro–Wilk test. The results revealed clear differences in synovial fluid proteomic profiles, highlighting a predominance of inflammatory proteins associated with immune activation in autoimmune arthritis, whereas degenerative arthritis showed a higher presence of biomarkers related to extracellular matrix degradation and structural joint damage; additionally, multivariate analysis demonstrated that integrating multiple biomarkers improves diagnostic accuracy and supports classification of arthritis type and disease progression. Accordingly, synovial proteomics emerges as a relevant tool to enhance differential diagnosis and guide more specific therapeutic interventions.
Downloads
References
Ali, N., Otte, A., Petersen, K. K., Ruetschi, U., Åkesson, K., Turkiewicz, A., Englund, M., Lohmander, L. S., & Struglics, A. (2022). Proteomics profiling of human synovial fluid suggests increased protein interplay in early-osteoarthritis (OA) that is lost in late-stage OA. Molecular & Cellular Proteomics, 21(4). https://doi.org/10.1016/j.mcpro.2022.100200
Cedeno, M., Murillo-Saich, J., Coras, R., Cedola, F., Brandy, A., Prior, A., Pedersen, A., Mateo, L., Martinez-Morillo, M., & Guma, M. (2023). Serum metabolomic profiling identifies potential biomarkers in arthritis in older adults: An exploratory study. Metabolomics, 19(4), 37. https://doi.org/10.1007/s11306-023-02004-y
Díaz-González, F. (2023). Artritis reumatoide. Medicine.
Domínguez, E. (2022). Diferenciación clínica de las artritis inflamatorias y degenerativas: retos actuales en el diagnóstico temprano. Revista Cubana de Reumatología, 24(2), 1–10.
Domínguez-Vera, P. A., Campos-Barrio, P. M., & López-Pacheco, J. (2023). Fisioterapia y osteoartritis: una revisión histórica de las técnicas utilizadas en el pasado y su relevancia actual. Fisioterapia.
Fernández-Cuadros, M. E., Pérez-Moro, O. S., Albaladejo-Florín, M. J., Álava-Rabasa, S., López-Muñoz, M. J., & Rodríguez-de-Cía, J. (2021). Un nuevo paradigma para el tratamiento de la osteoartritis de rodilla: el papel del ácido hialurónico, el plasma rico en plaquetas (PRP) y el ozono en la modulación de la inflamación: una revisión. Revista de la Sociedad Española del Dolor, 28(5), 282–291.
Frade-Sosa, B., Inciarte-Mundo, J., Mera-Varela, A., & Gómez-Puerta, J. A. (2022). Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors. Therapeutic Advances in Musculoskeletal Disease, 14. https://doi.org/10.1177/1759720X221124665
Inciarte-Mundo, J., Frade-Sosa, B., & Sanmartí, R. (2022). From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1001025
Lourido, L., Calamia, V., Fernández-Puente, P., Ruiz-Romero, C., Oreiro, N., & Blanco, F. J. (2021). A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: A prospective study using data from the Osteoarthritis Initiative. Osteoarthritis and Cartilage, 29(8), 1147–1154.
Macias-Muñoz, L., Inciarte-Mundo, J., Ruiz-Esquide, V., Hernández, M. V., Cabrera-Villalba, S., Ramirez, J., Cañete, J. D., & Gómez-Puerta, J. A. (2022). Analytical and clinical evaluation of DiaSorin Liaison fecal Calprotectin assay adapted for the measurement of calprotectin in serum and plasma in patients with rheumatoid arthritis. Journal of Clinical Laboratory Analysis, 36(3). https://doi.org/10.1002/jcla.24258
Mayoral-Rojals, V., Rodríguez-Sanz, J., Castán-Agueda, A., & colaboradores. (2021). Epidemiología, repercusión clínica y objetivos terapéuticos en la artrosis. Revista de la Sociedad Española del Dolor.
Miguel-Lavariega, A. (2023). Mecanismos inmunológicos en la artritis reumatoide y su impacto en el daño articular. Revista Colombiana de Reumatología, 30(3), 210–220. https://doi.org/10.1016/j.rcreu.2023.01.005
Oteo-Álvaro, Á. (2021). Mecanismos etiopatogénicos de la artrosis. Revista de la Sociedad Española del Dolor.
Padilla, N., Delgado, A., & colaboradores. (2023). Papel inmunomodulador de la vitamina D y los ácidos grasos poliinsaturados omega-3 en trastornos autoinmunes: Revisión de la literatura. Archivos Latinoamericanos de Nutrición, 73(3), 223–232.
Paz-González, R., Lourido, L., Calamia, V., Oreiro, N., Fernández-Puente, P., Ruiz-Romero, C., & Blanco, F. J. (2023). An atlas of the knee joint proteins and their role in osteoarthritis defined by literature mining. Molecular & Cellular Proteomics, 22(8), 100606. https://doi.org/10.1016/j.mcpro.2023.100606
Paz-González, R., Lourido, L., Calamia, V., Oreiro, N., Fernández-Puente, P., Ruiz-Romero, C., & Blanco, F. J. (2023). Proteomic profiling of human menisci from mild joint degeneration to end-stage osteoarthritis. Osteoarthritis and Cartilage Open, 5(4), 100417. https://doi.org/10.1016/j.ocarto.2023.100417
Pérez-García, S., Carrión, M., Gutiérrez-Cañas, I., Villanueva-Romero, R., Castro, D., Martínez, C., Juarranz, Y., & Mellado, M. (2021). Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable VIP-modulated inflammatory and degradative proteins in osteoarthritis. International Journal of Molecular Sciences, 22(12), 6441. https://doi.org/10.3390/ijms22126441
Puentes-Osorio, Y., Amariles, P., & colaboradores. (2021). Potential clinical biomarkers in rheumatoid arthritis with an omic approach. Autoimmunity Highlights, 12(1).
Rocha, F. A. C., Blanco, F. J., & colaboradores. (2023). Soluble biomarkers in osteoarthritis in 2022: Year in review. Osteoarthritis and Cartilage Open.
Santoscoy, M. (2021). Aplicaciones de la proteómica en enfermedades articulares inflamatorias. Revista Española de Reumatología, 48(4), 256–264. https://doi.org/10.1016/j.reuma.2021.02.003
Tornero-Crespo, M. M., Castán-Agueda, A., & colaboradores. (2021). Revisión del tratamiento farmacológico del dolor en artrosis. Revista de la Sociedad Española del Dolor.
Velásquez, J. (2023). Biomarcadores proteicos en enfermedades autoinmunes: avances recientes y aplicaciones clínicas. Salud, Ciencia y Espíritu, 9(1), 45–58.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Nathaly Silvana Cedeño Palacios (Autor/a)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





